Medical Thawing Systems Market Size, Share & Industry Analysis, By Type (Manual, Automated), By Sample (Blood, Semen, Ovum, Embryo, Others), By End User (Hospitals & ASCs, Blood Banks, Tissue Banks, Biotechnology & Pharmaceuticals Companies) And Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Medical thawing is an essential step during a blood transfusion. As the blood and plasma-based products are stored in cold conditions, thawing them is essential to ensure safe transfusion. A thawer system uses a microprocessor to regulate water bath temperature at an appropriate thawing temperature, i.e. 30-37 C. Increasing usage of fresh frozen plasma and blood products is rising the demand for medical thawing systems. Apart from this, thawing is also done at the cryopreservation of ovum and semen samples. Furthermore, growing donor base and increasing awareness about blood donations are likely to favor the market expansion.
The primary factors driving the global medical thawing systems market growth is the rising demand for blood and plasma products such as fresh frozen plasma. Furthermore, technological advancements to ease and simplify the thawing process resulting in a reduction in time and wastage is anticipated to foster the adoption of medical thawer. According to The American National Red Cross, nearly 36,000 units of red blood cells are needed every day in the U.S. This growing demand for blood transfusions is anticipated to augment market growth.
On the contrary, stringent government guidelines on product approval and thawing procedures are major factors that may hamper the market growth.
Key Market Driver -
Growing demand for blood and plasma products
Key Market Restraint -
Stringent government regulations
Market Segmentation:
By type, the global medical thawing systems market can be segmented into manual and automated. On the basis of the sample, the market can be bifurcated into blood, semen, ovum, embryo, and others. In terms of end user, the market can be segmented into hospitals & ASCs, blood banks, tissue banks, biotechnology and pharmaceutical companies, and others.
From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Key Players Covered:
The major companies in the global medical thawing systems market report include General Electric, HETTICH AG, FreMon Scientific, Inc., Helmer Scientific Inc., QED Scientific Ltd., KW Scientific Apparatus srl, LABCOLD, BARKEY, Brooks Life Sciences, and others.
Key Insights
- Technological Advancements in the Medical Thawing Systems
- Blood and Blood Products Usage Statistics – By Key Brands/Manufacturers
- COVID-19 Impact on the Global Medical Thawing Systems Market
- New Product Launches
- Key Industry Developments – Mergers, Acquisitions, and Partnerships
Regional Analysis:
The global medical thawing systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the market throughout the forecast period. Growth of the market in North America can be attributed to the increasing number of blood donors and new product launches. According to The American National Red Cross, approximately 21 million blood components are transfused every year in the U.S. This is expected to fuel the growth of the market in North America. In Europe, the market is poised to surge owing to technological advancements and the rising prevalence of blood diseases. Asia Pacific is estimated to witness the maximum growth due to the increasing incidence of haemorrhage and rising awareness regarding semen and ovum cryopreservation. In Latin America and the Middle East & Africa the market is likely to propel owing to the increasing number of blood banks and rising prevalence of sickle cell disease.
To gain extensive insights into the market, Request for Customization
Segmentation
ATTRIBUTE | DETAILS |
By Type |
|
By Sample |
|
By End User |
|
By Geography |
|
Medical Thawing Systems Industry Developments
- In June 2020, FreMon Scientific, Inc. received FDA approval for ZipThaw for thawing of frozen plasma in the U.S.
- In September 2017, General Electric announced the launch of its VIA Thaw series, VIA Thaw CB1000, which can be used for thawing of cell therapies cryopreserved in bags.
- Ongoing
- 2023
- 2019-2022
Personalize this Research
- Granular Research on Specified Regions or Segments
- Companies Profiled based on User Requirement
- Broader Insights Pertaining to a Specific Segment or Region
- Breaking Down Competitive Landscape as per Your Requirement
- Other Specific Requirement on Customization
Healthcare Clients
